Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Mohanraj Ramachandran(Uppsala University), Anna Dimberg(Uppsala University), Lene Uhrbom(Uppsala University), Despoina Kourougkiaouri(Uppsala University), Tiarne van de Walle(Uppsala University), Alessandra Vaccaro(Uppsala University), Kalyani Vemuri(Uppsala University), Luuk van Hooren(Uppsala University), Konstantinos Vazaios(Utrecht University), Maria Georganaki(Uppsala University), Miika Martikainen(Uppsala University), Ilkka Pietilä(University of Helsinki), Thomas Olsson Bontell(Sahlgrenska University Hospital), Roberta Lugano(Science for Life Laboratory), Asgeir Store Jakola(Sahlgrenska University Hospital), Bengt Westermark(Science for Life Laboratory), Georgia Tsaridou(Uppsala University), Di Yu(Xishuangbanna Tropical Botanical Garden), Marie Hedlund(Uppsala University), Magnus Essand(Uppsala University)
Cited by 145
Related Papers
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
|Physiological Reviews|1999|2.5k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k